| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $477.7M | +52.2% |
| R&D Expense | $1.05B | -8.4% |
| SG&A Expense | $1.43B | +65.7% |
| Operating Income | -$2.21B | -20.8% |
| Interest Expense | $106K | -95.5% |
| Pre-tax Income | -$2.12B | -15.4% |
| Income Tax | -$15.0M | -915.3% |
| Net Income | -$2.10B | -15.0% |
| EPS (Basic) | -$1.25 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.32B | -15.1% |
| Accounts Receivable | $80.9M | -38.5% |
| Inventory | $4.4M | +29.8% |
| Current Assets | $1.45B | -15.8% |
| Total Assets | $2.54B | +22.6% |
| Current Liabilities | $173.0M | +28.3% |
| Total Liabilities | $803.0M | +59.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$252.2M | +0.6% |
| Capital Expenditures | $52.3M | -7.5% |
| Investing Cash Flow | -$67.4M | +8.0% |
| Financing Cash Flow | $95.3M | -93.8% |
| Free Cash Flow | -$304.5M | +1.9% |
| +7.4% |
| EPS (Diluted) | -$1.25 | +10.1% |
| Stockholders' Equity |
| $1.74B |
| +15.3% |